As part of the comprehensive research strategy aimed at stopping MS (Multiple Sclerosis), the National Multiple Sclerosis Society in the US has committed $28 million to support 84 new MS research projects.
"MS research is a top National MS Society priority, with increasing annual investments to drive solutions for every person with MS," says Cynthia Zagieboylo, President and CEO of the Society. "We fund the entire research spectrum, propelling novel ideas into the lab, translating breakthroughs into clinical trials, and moving success in clinical trials into new treatments for people living with MS."
Multiple Sclerosis
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses
Advertisement
The society pursues all promising paths, and focuses on priority areas including progressive MS, nervous system repair, gene/environmental risk factors and wellness and lifestyle.
Bruce Bebo, PhD, Executive Vice President, National MS Society, said, "These innovative new projects add to the Society's comprehensive efforts to stop MS, restore function and end MS forever. While we fund more research than any other MS organization in the world, we also convene and empower the research community toward breakthroughs that can help people with MS live their best lives now."
![Multiple Sclerosis Treatment and Modify]( "Multiple Sclerosis Treatment and Modify")
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity and relieve symptoms.
Multiple sclerosis interrupts the flow of information within the brain and between the brain and the body. MS is diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. Globally, over 2.3 million people live with the unpredictable challenges of multiple sclerosis.
Source: Medindia
Multiple Sclerosis Treatment and Modify
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity and relieve symptoms.
Advertisement
Multiple sclerosis interrupts the flow of information within the brain and between the brain and the body. MS is diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. Globally, over 2.3 million people live with the unpredictable challenges of multiple sclerosis.
Source: Medindia
Nanoparticles can Arrest Multiple Sclerosis
Nanoparticles can be easily produced in laboratory and can be standardized for manufacturing and they can render the potential therapies quite cost friendly and easily accessible to general people.
Advertisement
 Chronic Cerebrospinal Venous Insufficiency (CCSVI) is Not Associated With Multiple SclerosisThe medical fraternity is divided over the theory whether chronic cerebrospinal venous insufficiency is linked with multiple sclerosis. Here's what the latest research says. | Advertisement
|
Advertisement
Recommended Readings
Latest General Health News
In a tragic incident, a woman in the US experienced the loss of all her limbs as a result of a bacterial outbreak linked to the consumption of contaminated fish.
FluMos-v2, a unique universal influenza vaccine candidate, undergoing a phase 1 trial at NIH, increases recipients' immunity against many influenza viruses.
In Pakistan, the polio campaign focuses on more than 270,000 children under the age of five years, residing in areas with insufficient vaccine coverage.
Dangers of Wrong Diagnosis: Diagnostic errors in healthcare can increase the risk of permanent disabilities and deaths.
Due to our constant connectivity and the ability to be accessible at all times, it has become challenging to separate from work and fully participate in personal life.
